Nivolumab-associated Stevens-Johnson syndrome in a patient with lung cancer.

Nivolumab is a fully human immunoglobulin G4 immune checkpoint inhibitor antibody approved for use in the treatment of several malignancies such as lung cancer. Cutaneous reactions to checkpoint inhibitors are frequent, appearing in approximately 40% of patients. Although most of the reactions are well tolerated, these drugs can lead to severe cutaneous adverse reactions, but a quick recognition of the symptoms can significantly decrease their mortality.

[The Spanish Society of Cytology: Quality control program of gynecological cytology].

Introduction: In Spain, the guidelines for cervical cancer screening include a recommendation to enroll in external quality control programs. The Spanish Society of Cytology (SEC) has initiated its own quality control program of gynecological cytology (QCPGC).

Aim: To describe and discuss the results of the second round of SEĆs QCPGC.

[Descriptive study of cervical intraepithelial neoplasia grade III (CIN III) cases in the area of the hospital of Barbastro].

Objective: A description of early diagnosis of cervical cancer in the Barbastro Hospital area.

Design: Descriptive and retrospective study on all the CIN III cases collected in the Tumor Hospital Registry from 1989 to 1998. To correlate the data to the population covered by the hospital.

Gastric carcinoid tumour. A clinicopathologic and immunohistochemical study of four cases.

Over the last decade a great increase in the frequency of Gastric Carcinoid Tumours has been detected being considered by some authors as the most frequent digestive carcinoid. These have been divided into three types: I) those associated with chronic atrophic gastritis; II) associated with Zollinger-Ellison syndrome, and III) sporadic lesions. We present four cases of gastric carcinoid type I (3 women and 1 man) two of them associated with pernicious anemia and another two with iron deficiency anemia.

[Suprarenal myelolipoma: an infrequent cause of acute abdomen].

Adrenal myelolipoma is a benign tumor associated with chronic disease and a long survival after surgical exeresis. It is scarcely symptomatic and only exceptionally has an acute onset, wherein lies the interest of this report.